Biotech Archives - Page 99 of 795

2 minute read

FDA Approves Irinotecan Liposome For First-line Treatment Of Metastatic Pancreatic Adenocarcinoma

February 13, 2:19 PM

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-irinotecan-liposome-first-line-treatment-metastatic-pancreatic-adenocarcinomaOn February 13, 2024, the Food and Drug Administration approved

IPSEY

2 minute read

Why Is Biogen Stock Trading Lower On Tuesday?

By Vandana Singh

February 13, 1:42 PM

Biogen's Q4 2023 performance, with $2.39 billion in sales, adjusted EPS of $2.95, and updates on key drugs.

BIIB

1 minute read

Why Is Brain Cancer Focused-Biodexa Pharmaceuticals Stock Trading Higher Today?

By Vandana Singh

February 13, 1:12 PM

Biodexa Pharmaceuticals surges 30.3% in premarket on Tuesday. Discover the latest SEC filing, cancer research updates, and patent news.

BDRX

1 minute read

Calliditas Therapeutics Announces That The U.S. Patent And Trademark Office Issued Patent #11896719, Entitled “New Pharmaceutical Compositions,” On January 24, 2024 With Validity As Of Today, February 13, 2024

By Benzinga Newsdesk

February 13, 12:28 PM

Calliditas Therapeutics AB (NASDAQ:CALT, Nasdaq Stockholm: CALTX))) ("Calliditas") today announced that the United States Patent and Trademark Office (USPTO) issued patent no. 11896719, entitled "New Pharmaceutical

CALT

2 minute read

What’s Going With Hereditary Angioedema-Focused KalVista Pharmaceuticals Stock On Tuesday?

By Vandana Singh

February 13, 12:02 PM

Results from KalVista Pharmaceuticals' Phase 3 KONFIDENT trial. Sebetralstat, an oral on-demand therapy, shows efficacy for hereditary angioedema.

KALV

2 minute read

Renovaro Biosciences Faces Turmoil After Hindenburg Report Accusing Questionable Merger And Governance, Stock Crashes

By Vandana Singh

February 13, 12:01 PM

Renovaro Biosciences navigates challenges – from a controversial merger with GEDi Cube to allegations of securities law violations.

NVDA

3 minute read

Masimo Announces FDA-Cleared “Over-The-Counter” Fingertip Pulse Oximeter

By Benzinga Newsdesk

February 13, 10:07 AM

Masimo MightySat® Medical Provides Clinically Proven Masimo SET® Pulse Oximetry to Consumers for Medical Use Without a PrescriptionMasimo (NASDAQ:MASI) announced today FDA clearance of MightySat® Medical,

MASI

2 minute read

GeoVax Announces Multiple Actions By Global Patent Offices Strengthening The Company’s Intellectual Property Assets; Intellectual Property Assets Strengthened For Cancer Immunotherapy Program And For Marburg Virus And HIV Vaccines

By Benzinga Newsdesk

February 13, 10:05 AM

Intellectual Property Assets Strengthened for Cancer Immunotherapy Programand for Marburg Virus and HIV VaccinesATLANTA, GA, Feb. 13, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NASDAQ:GOVX), a

GOVX

1 minute read

EXCLUSIVE: Adial Pharmaceuticals Announces New US Patent Covering Its Molecular Genetic Diagnosing For Alcohol, Drug Dependence

By Vandana Singh

February 13, 9:45 AM

Adial Pharmaceuticals US patent, enhancing genetic diagnostic coverage for tailored treatment of alcohol and drug dependencies, including opioid use disorder. Learn more about AD04's potential in addressing a $40 billion U

ADIL